Image of people using integrated systems on their computers

Vālenz Embeds Spiro into Ecosystem for Added Insights into Customer Needs

PHOENIX, Ariz. (December 19, 2019) — With a laser focus on changing the trajectory of total healthcare spending, which surpassed $3.6 trillion in 2018 and is expected to rise 5.5% to exceed $3.8 trillion in 2019, Vālenz™ announced the integration of Spiro into its health administrative ecosystem. As a proactive relationship management solution typically used to boost efficiency and effectiveness, Spiro provides Valenz teams with a transparent lens into new and existing client activity. The resulting insights quickly illuminate new ways to disrupt the cost curve for Valenz clients, which include self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers.

“By embedding Spiro into our business processes, we can extract meaningful data from client interactions, giving everyone across our enterprise actionable business intelligence to help our clients reduce their total cost of care,” said Rob Gelb, Chief Revenue Officer at Valenz. Spiro’s AI platform offers tremendous efficiencies for the Valenz team and, as Gelb explains, “It’s a game-changer for our clients because now we can consolidate their information across text messages, calls and documents to rapidly deploy new solutions for our clients.”

According to Adam Honig, CEO and co-founder of Spiro, companies that use Spiro’s AI-driven, proactive relationship management platform can expect to work smarter and close faster – and for innovative firms like Valenz, there are opportunities to take things to the next level. “I’m impressed at how Valenz is integrating our platform into its ecosystem to generate value well beyond their own benefit,” Honig said. “They are clearly a forward-thinking firm, using our platform to engage early and often to reduce the cost of healthcare for their clients.”

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Spiro.AI

Spiro is the first proactive relationship management platform. Natively built on artificial intelligence, Spiro provides a single solution encompassing traditional CRM, sales enablement and telephony. Spiro’s AI engine eliminates the need for data entry and proactively guides salespeople to the right actions at the right time. Customers report collecting 8 times more data, reaching 47% more prospects and closing 20% more deals after using Spiro. For more information, visit www.spiro.ai.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.